Skip to content

Author

Haifa F. Alotaibi

We have 4 of 35 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Changes in CGM-Derived Glycemic Metrics and Triglyceride-Glucose Index During Ramadan in Adults With Type 2 Diabetes Using Real-Time Continuous Glucose Monitoring.

PURPOSE To evaluate longitudinal changes in continuous glucose monitoring (CGM)-derived glycemic metrics, glycemia risk indices (GRIs), triglyceride-glucose (TyG) index, and diabetes self-management before, during, and after Ramadan fasting in adults with type 2 diabetes (T2D) receiving non-intensive diabetes therapy a...

A. A. Al Hayek, Wael M. Alzahrani, Mo'men Al Ajlouni et al. · 0 citations
Review Open access Oct 2026

Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective

Background/Objectives: Obesity is a chronic, multifactorial condition driven by complex neuroendocrine and metabolic pathways that limit the long-term success of lifestyle interventions. Pharmacotherapy has advanced from early monoaminergic agents to incretin-based and multi-receptor agonists with substantially improve...

Ishtiaque Ahmad, Sarfuddin Azmi, Monirah A. Albabtain et al. · 0 citations
Review Open access Sep 2026

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

BACKGROUND Psoriasis is a chronic, immune-mediated inflammatory skin disease that affects approximately 5.3% of the population in the Kingdom of Saudi Arabia (KSA). Thus, we aim to develop updated evidence-based clinical practice guidelines for the management of adults and pediatric patients with moderate-to-severe pla...

M. Fatani, Y. Binamer, D. Alessa et al. · 0 citations
Review Open access Oct 2026

Effectiveness of Continuous Glucose Monitoring in Non-Intensively Managed Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

BACKGROUND The effectiveness of continuous glucose monitoring (CGM) in adults with type 2 diabetes (T2D) not receiving intensive insulin therapy remains incompletely established, particularly regarding glycemic metrics beyond glycated hemoglobin (HbA1c). METHODS We conducted a systematic review and meta-analysis of r...

A. A. Al Hayek, Wael M. Alzahrani, Haifa F. Alotaibi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.